(Q37157579)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

S L Ong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A Sachdeva

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Garcea

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

G Gravante

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M S Metcalfe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D M Lloyd

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D P Berry

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

1 reference

9 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

7 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

3213-3217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18465243%20AND%20SRC:MED&resulttype=core&format=json

Type 2 diabetes mellitus and CA 19-9 levels

7 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-008-0289-8

Impact of endoscopic ultrasound-guided fine needle biopsy for diagnosis of pancreatic masses

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-008-0289-8

Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer

21 January 2018

1 reference

12 December 2020

Serum levels of CA19-9 in patients with nonmalignant respiratory diseases

1 reference

12 December 2020

A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve

1 reference

12 December 2020

Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis

1 reference

12 December 2020

Autoimmune pancreatitis: medical and surgical management.

1 reference

12 December 2020

Mirizzi syndrome complicating an anomalous biliary tract: a novel cause of a hugely elevated CA19-9.

1 reference

12 December 2020

Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice

1 reference

12 December 2020

Evaluation of the bilio-pancreatic region using endoscopic ultrasonography in patients referred with and without abdominal pain and CA 19-9 serum level elevation

1 reference

12 December 2020

Serum levels of carbohydrate antigenic determinant (CA 19.9) in obstructive jaundice

1 reference

12 December 2020

CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice

1 reference

12 December 2020

Incidence and clinical significance of hyperamylasemia after endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) of pancreatic lesions: a prospective and controlled study

1 reference

12 December 2020

Papillary adenocarcinoma of the renal pelvis and ureter producing carcinoembryonic antigen, carbohydrate antigen 19-9 and carbohydrate antigen 125

1 reference

12 December 2020

Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer

1 reference

12 December 2020

Molecular genetic analysis of the human Lewis histo-blood group system

1 reference

12 December 2020

Performance characteristics of five automated CA 19-9 assays.

1 reference

12 December 2020

Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases

1 reference

12 December 2020

CA 19-9 to rule out pancreatic or biliary cancer among patients with cholestasis: an unsuitable test?

1 reference

12 December 2020

The Use of Adjusted Preoperative CA 19-9 to Predict the Recurrence of Resectable Pancreatic Cancer

1 reference

12 December 2020

Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?

1 reference

12 December 2020

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer

1 reference

12 December 2020